| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities: | |||||||||
Net loss | |||||||||
-13,951 | -8,101 | -6,202 | -11,250 | -10,576 | -26,627 | -17,640 | -11,136 | -10,875 | -15,668 |
Loss from discontinued operations | |||||||||
-216 | 0 | 3,983 | -5,120 | - | - | - | - | - | - |
Loss from continuing operations | |||||||||
-13,735 | -8,101 | -10,185 | -6,130 | - | - | - | - | - | - |
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities: | |||||||||
Depreciation and amortization | |||||||||
- | - | 757 | 936 | 4,063 | - | - | - | - | 4,774 |
Depreciation | |||||||||
1,899 | 726 | - | - | - | 3,956 | 3,025 | 3,430 | 3,532 | - |
Amortization | |||||||||
31 | 47 | - | - | - | - | - | - | - | - |
Stock and share-based compensation | |||||||||
1,360 | 886 | 1,073 | 1,275 | 898 | - | - | 1,161 | 1,475 | 2,141 |
Amount of gain (loss) from noncash settlement with seller. | |||||||||
849 | 0 | - | - | - | - | - | - | - | - |
Amortization | |||||||||
- | - | - | - | - | 2,593 | 1,023 | 1,182 | 1,448 | - |
Provision for bad debts | |||||||||
472 | 0 | - | - | 185 | 251 | 226 | 401 | 162 | 153 |
Financing expense | |||||||||
- | - | - | - | - | 2,072 | 564 | 2,184 | 0 | - |
Impairment of property | |||||||||
- | - | - | - | - | - | 300 | 1,069 | 1,592 | 1,900 |
Loss on disposal of property | |||||||||
- | - | - | - | - | - | - | - | - | -943 |
Change in fair value of derivative warrant liabilities | |||||||||
- | - | 670 | 1,625 | 1,001 | -1,209 | -1,029 | 5,420 | 332 | -349 |
Loss on extinguishment of debt | |||||||||
- | - | -8,290 | 0 | -1,904 | -906 | -2,891 | -4,941 | 0 | - |
Goodwill impairment | |||||||||
- | - | - | - | 0 | - | - | - | - | - |
Gain on resolution of Irgovel purchase litigation | |||||||||
- | - | - | 1,598 | 0 | - | - | - | - | - |
Share-based compensation, employees and directors | |||||||||
- | - | - | - | - | -729 | -538 | - | - | - |
Interest accreted | |||||||||
- | - | 1,000 | 639 | 455 | 7,058 | 315 | - | - | - |
Recovery from former customer | |||||||||
- | - | - | - | - | - | - | - | 1,000 | 0 |
Settlement with former officer | |||||||||
- | - | - | - | - | - | - | - | 267 | 0 |
Deferred taxes | |||||||||
- | - | -5,046 | -1,869 | -192 | -1,304 | -1,248 | -1,935 | -345 | -935 |
Foreign exchange loss | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Reorganization expenses | |||||||||
- | - | - | - | - | - | - | - | - | 1,033 |
Other | |||||||||
-13 | 14 | -32 | -5 | -75 | -169 | 68 | -775 | -772 | -42 |
Changes in operating assets and liabilities, net of impact of acquisitions: | |||||||||
Accounts receivable | |||||||||
1,102 | -331 | 179 | 227 | -63 | 766 | -256 | 462 | 577 | 63 |
Inventories | |||||||||
-332 | 138 | -279 | -808 | 677 | 138 | 561 | -201 | -343 | -334 |
Accounts payable and accrued expenses | |||||||||
-296 | 935 | -679 | -201 | 1,392 | -215 | 3,383 | 215 | 517 | -1,130 |
Commodities payable | |||||||||
-1,340 | 176 | - | - | - | - | - | - | - | - |
Pre-petition liabilities | |||||||||
- | - | - | - | - | - | - | -1,615 | -4,790 | -552 |
Other | |||||||||
235 | 89 | -303 | 467 | 383 | -40 | -765 | -187 | 807 | -173 |
Net cash used in operating activities of continuing operations | |||||||||
- | - | -5,025 | -8,454 | -3,794 | -10,067 | -5,202 | - | - | - |
Net cash provided by operating activities of discontinued operations | |||||||||
- | - | 1,251 | 4,519 | - | - | - | - | - | - |
Proceeds from sale of property | |||||||||
- | - | - | - | 0 | - | - | - | - | -772 |
Net cash used in operating activities, before reorganization items | |||||||||
- | - | - | - | - | - | - | - | - | -6,506 |
Reorganization expenses | |||||||||
- | - | - | - | - | - | - | - | - | -1,033 |
Change in accounts payable for reorganization items | |||||||||
- | - | - | - | - | - | - | - | - | 198 |
Net cash used for reorganization items | |||||||||
- | - | - | - | - | - | - | - | - | -835 |
Net cash used in operating activities | |||||||||
-13,450 | -5,241 | -3,774 | -3,935 | - | - | - | -4,822 | -9,152 | -7,341 |
Cash flows from investing activities: | |||||||||
The cash outflow associated with the acquisition of business during the period. | |||||||||
3,777 | 0 | - | - | - | - | - | - | - | - |
The cash outflow to settle notes receivable due from an acquired company as part of a business combination. | |||||||||
- | - | 0 | - | - | - | - | - | - | - |
Purchases of property and equipment | |||||||||
4,219 | 3,248 | 862 | 360 | 1,068 | 5,423 | 3,119 | 6,482 | 6,867 | - |
Proceeds from sale of property, plant and equipment | |||||||||
- | - | - | - | - | - | - | - | - | 8,872 |
Acquisition of additional interests in Rice Science and Rice Rx | |||||||||
- | - | - | - | - | - | - | - | - | 0 |
Change in restricted cash | |||||||||
- | - | - | - | 0 | - | - | - | 200 | 0 |
Acquisition of Golden Ridge, net of cash acquired | |||||||||
0 | 1,862 | 0 | - | - | 725 | 0 | - | - | - |
Disbursements of notes receivable | |||||||||
0 | 475 | - | - | - | - | - | - | - | - |
Receipts on notes receivable | |||||||||
- | - | - | - | - | - | - | 700 | 1,100 | 1,200 |
Other | |||||||||
- | - | - | - | - | - | - | -244 | 210 | 26 |
Net cash used in investing activities | |||||||||
- | - | 15,139 | -716 | - | - | - | -4,962 | -6,177 | 9,274 |
Proceeds from sales of property | |||||||||
- | - | - | - | - | 23 | 829 | 576 | 0 | - |
Payment for license | |||||||||
- | - | - | - | - | - | -1,200 | 0 | - | - |
Net cash used in investing activities - continuing operations | |||||||||
-7,996 | -5,585 | -862 | -360 | -1,068 | -6,125 | -3,490 | - | - | - |
Net cash used in investing activities - discontinued operations | |||||||||
-475 | 0 | 16,001 | -356 | - | - | - | - | - | - |
Cash flows from financing activities: | |||||||||
Payments on factoring agreement | |||||||||
3,325 | 0 | - | - | - | - | - | - | - | - |
The cash inflow from borrowings to finance investment in shares, managed funds and other approved financial products. | |||||||||
1,853 | 0 | - | - | - | - | - | - | - | - |
The cash outflow from payments to finance investment in shares, managed funds and other approved financial products. | |||||||||
1,853 | 0 | - | - | - | - | - | - | - | - |
Advances on factoring agreement | |||||||||
5,134 | 0 | - | - | - | - | - | - | - | - |
Payments of debt and finance lease liabilities | |||||||||
363 | 16 | - | - | - | - | - | - | - | - |
The cash inflow from issuance of common stock and pre-funded warrant, net of issuance costs. | |||||||||
19,422 | 0 | - | - | - | - | - | - | - | - |
Proceeds from common stock warrant exercises | |||||||||
2,072 | 11,106 | 0 | - | - | - | - | 0 | - | - |
Proceeds from common stock option exercises | |||||||||
156 | 28 | - | - | - | - | - | - | - | - |
Payments of debt | |||||||||
- | - | 19,744 | 32,344 | 23,823 | 18,971 | 18,404 | 12,610 | 8,818 | 5,716 |
Proceeds from issuance of debt, net of issuance costs | |||||||||
- | - | 3,779 | 30,629 | 25,991 | 15,699 | 20,218 | 15,189 | 15,056 | 3,399 |
Proceeds from issuance of debt and warrants, net of issuance costs | |||||||||
- | - | 5,518 | 300 | 0 | 5,379 | 575 | 3,563 | 506 | 0 |
Proceeds from issuance of stock which is not included within permanent equity net of issuance costs. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. | |||||||||
- | - | 1,747 | 2,554 | 0 | - | - | - | - | - |
Proceeds from issuance of common stock, net of issuance costs | |||||||||
- | - | 2,778 | 0 | - | - | - | - | - | - |
Proceeds from sale of membership interests in Nutra SA | |||||||||
- | - | - | - | 0 | - | - | - | 11,625 | 0 |
Payment of payroll taxes on stock-based compensation through shares withheld | |||||||||
- | - | - | - | 0 | - | - | - | - | - |
Proceeds from issuance of common stock and warrants, net of costs | |||||||||
- | - | - | - | - | 13,296 | 7,617 | 0 | - | - |
Proceeds from sale of membership interests in Nutra SA, net of costs | |||||||||
- | - | - | - | - | - | 1,200 | 1,500 | - | - |
Proceeds from sale of membership interests in RBT PRO, net of costs | |||||||||
- | - | - | - | - | - | 1,200 | 0 | - | - |
Change in accumulated Yield in Nutra SA | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Other | |||||||||
0 | -1 | -23 | -43 | - | -329 | 408 | - | - | - |
Net cash used in financing activities of continuing operations | |||||||||
- | - | -5,945 | 1,096 | 2,168 | 15,074 | 12,814 | - | - | - |
Net cash provided by financing activities of discontinued operations | |||||||||
- | - | 1,062 | 907 | - | - | - | - | - | - |
Net cash provided by financing activities | |||||||||
23,096 | 11,117 | -4,883 | 2,003 | - | - | - | 7,642 | 18,369 | -2,317 |
Effect of exchange rate changes on cash and cash equivalents of discontinued operations | |||||||||
- | - | 154 | 103 | - | - | - | - | - | - |
Net change in cash and cash equivalents and restricted cash | |||||||||
1,175 | 291 | 6,636 | -2,545 | - | - | - | - | - | - |
Cash and cash equivalents and restricted cash, beginning of period [Abstract] | |||||||||
Effect of exchange rate changes on cash and cash equivalents | |||||||||
- | - | - | - | 154 | -363 | -71 | -147 | -248 | -31 |
Net change in cash and cash equivalents | |||||||||
- | - | - | - | -2,540 | -1,481 | 4,051 | -2,289 | 2,792 | -415 |
Supplemental disclosures: | |||||||||
Cash paid for interest | |||||||||
81 | 10 | 811 | 1,849 | - | - | - | - | - | - |
Cash paid for interest | |||||||||
- | - | - | - | 1,817 | 2,628 | 2,537 | 1,651 | 1,551 | 990 |
Cash paid for income taxes of continuing operations | |||||||||
- | - | - | 20 | 26 | 0 | 0 | 0 | 0 | 6 |